1-3 of 3
Kyle Lenz
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Significant In Vivo Sensitivity to Aurora Kinase Inhibition in TCF3-Hlf rearranged Acute Lymphoblastic Leukemia

Bill H. Chang, MD PhD, Jessica Leonard, MD, Joelle Wolf, Michelle Degnin, BS, Kyle Lenz, MD, Beth Wilmot, PhD, Charles G. Mullighan, MBBS, MD, Mignon L. Loh, MD, Stephen P. Hunger, MD, Jeffrey W. Tyner, PhD, Brian J. Druker, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 4026.
https://doi.org/10.1182/blood-2018-99-115706
Published: 2018
Journal Articles

Dasatinib Shows Therapeutic Potential in the Murine Xenograft Model for TCF3 rearranged Acute Lymphoblastic Leukemia

Kyle Lenz, Sarah Thompson, Natalya A. Goloviznina, B.S., Jianya Huan, PhD, Dorian H LaTocha, BS, Brian J. Druker, Jeffrey W. Tyner, Peter Kurre, MD, Bill H Chang, MD PhD
Journal: Blood
Blood (2014) 124 (21): 3718.
https://doi.org/10.1182/blood.V124.21.3718.3718
Published: 2014
Journal Articles

AML Exosomes Regulate Stromal Bystander Cells and Provide a Novel RNA Biomarker Platform

Jianya Huan, Ph.D., Noah Hornick, BS, Kyle Lenz, Natalya A Goloviznina, BS, Amy M. Skinner, Ph.D., Jeffrey W Tyner, PhD, Charles T Roberts, PhD, Peter Kurre, M.D.
Journal: Blood
Blood (2012) 120 (21): 1378.
https://doi.org/10.1182/blood.V120.21.1378.1378
Published: 2012